Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trials

European Heart Journal

Volumn 17, Issue 5, 1996, Pages 674-681

  Cleland, J G F ^a   Cowburn, P J ^a   Falk, R H ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Aspirin; Atrial fibrillation; Heart failure; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULATION; ARTICLE; BLEEDING; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART ATRIUM FIBRILLATION; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STROKE;

EID: 0029893924     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a014933     Document Type: Article

References (0)